CAS: 13374-31-7; (1R,2R)-2-Aminocyclohexanol Hydrochloride

该化合物是一个化学化合物,其特点是有矿物质和酒精功能组,是一种盐酸盐,表明它是该矿物质的盐酸盐,表明它是该矿的盐酸盐,该化合物一般是白色晶状固体,由于存在盐酸组而溶于水中,这增加了它的极度.这一名称指该分子的具体立体化学学,表明它有固定的原子三维安排.由于它具有潜在的再活性,而且与盐类一起工作时需要安全防范,正确处理和储存是不可或缺的.

结构式图片

欧盟法规

C&L通报

上下游产品

N-(cis-2-hydroxycyclohexyl)benzamide cis-2-benzamid°Cyclohexyl benzoate 1,2-cis-(1,3-dihydroisobenzofuran-1-ylideneamino)cyclohexanol (1S,2R)-2-[3H-Isobenzofuran-(1Z)-ylideneamino]-cyclohexanol cis-β-Hydroxycyclohexyl-trimethylammonium-iodid 6-chloro-5-(4-chlorophenyl)-N-[(1R,2R)-2-hydroxycyclohexyl]-3-pyridine carboxamide

合成工艺路线路线简述

  • 合成目标产物 [1S,2R]-Trans-2-Aminocyclohexanol Hydrochloride 主要起始原料 Cyclohexene Oxide
  • (文献来源)合成步骤主要原料 Cyclohexene Oxide
氧化环己烯置于盐酸,[((R,R)-3,5-T-Bu-Salen)Co(III)(Otf)],Potassium Hydroxide体系中,用 乙醚,乙醇,正己烷,二氯甲烷,水,乙腈 用作溶剂,化学反应 44.0H,反应生成(1R,2R)-2-氨基环己醇盐酸盐
参考文献:A Practical Method For The Synthesis Of Highly Enantioenriched Trans-1,2-Amino Alcohols
标题:A Practical Method For The Synthesis Of Highly Enantioenriched Trans-1,2-Amino Alcohols
摘要:A Highly Enantioselective Addition Of Phenyl Carbamate To Meso-Epoxides Has Been Developed To Efficiently Generate Protected Trans-1,2-Amino Alcohols. This Transformation Is Promoted By An Oligomeric (Salen)Co-Otf Catalyst And Has Been Used To Prepare Two Useful 2-Aminocycloalkanol Hydrochlorides In Enantiopure Form On A Multigram Scale From Commercially Available Starting Materials.
Doi:10.1021/ol401013S

海关参考信息

专利信息


专利号:US-6960601-B2
优先权日:2001-09-24
标题 :Preparation and use of imidazole derivatives for treatment of obesity
发明人:SMITH ROGER A; O'CONNOR STEPHEN J; WIRTZ STEPHAN-NICHOLAS; WONG WAI C; CHOI SOONGYU; KLUENDER HAROLD C E; SU NING; WANG GAN; ACHEBE FURAHI; YING SHIHONG
权利人:BAYER PHARMACEUTICALS CORP
摘要:This invention relates to substituted imidazole derivatives which have been found to suppress appetite and induce weight loss. The invention also provides methods for synthesis of the compounds, pharmaceutical compositions comprising the compounds, and methods of using such compositions for inducing weight loss and treating obesity and obesity-related disorders.

专利号:WO-9967219-A1
优先权日:1998-06-22
标 题:Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
发明人:AUDIA JAMES E; PORTER WARREN J; THOMPSON RICHARD C; WILKIE STEPHEN C; STACK DOUGLAS R; SHI QING
权利人:ELAN PHARM INC; LILLY CO ELI; AUDIA JAMES E; PORTER WARREN J; THOMPSON RICHARD C; WILKIE STEPHEN C; STACK DOUGLAS R; SHI QING
摘要:Compounds of formula (I), wherein W is a cyclic group of the type (2); (3); Y is represented by the formula (II); these compounds inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:US-9994550-B2
优先权日:2014-01-07
标题 :Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
发明人:WAGMAN ALLAN S; JOHNSON RUSSELL J; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W; DUKE GREG; OHOL-GUPTA YAMINI; HEUER TIMOTHY; O'FARRELL MARIE
权利人:3 V BIOSCIENCES INC
摘要:Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds.

专利号:US-7390801-B2
优先权日:1996-12-23
标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
发明人:THORSETT EUGENE D; PLEISS MICHAEL A; LATIMER LEE H; JOHN VARGHESE; FREEDMAN STEPHEN; BRITTON THOMAS C; AUDIA JAMES A; REEL JON K; DRESSMAN BRUCE A; DROSTE JAMES J; HENRY STEVEN S; STUCKY RUSSELL D; PORTER WARREN J
权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:US-10226449-B2
优先权日:2013-12-20
标 题:Heterocyclic modulators of lipid synthesis and combinations thereof
发明人:HEUER TIMOTHY SEAN; OSLOB JOHAN D; MCDOWELL ROBERT S; JOHNSON RUSSELL; YANG HANBIAO; EVANCHIK MARC; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W; DUKE GREGORY; OHOL-GUPTA YAMINI; O'FARRELL MARIE
权利人:3 V BIOSCIENCES INC
摘要:Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

专利号:US-6838455-B2
优先权日:1998-06-22
标题 :Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
发明人:AUDIA JAMES E; PORTER WARREN J; THOMPSON RICHARD C; WILKIE STEPHEN C; STACK DOUGLAS R; SHI QING
权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
大赛璐药物手性技术(上海)有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.daicelchiraltech.cn
企业联系电话:021-50460086-9👤
📞大赛璐药物手性技术(上海)有限公司 ⚠️参考联系方式
联系人:陆青
电话:021-50460086-9

传真:021-50462321
邮箱:lu_qing@dctc.daicel.com
通信地址: 上海市浦东新区荷香路32号
邮编: 200131
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市浦东新区荷香路32号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s10118-020-2413-y
摘要:Ren W, Wang R, Ren B, Gu G, Yue T. Mechanism-inspired Design of Heterodinuclear Catalysts for Copolymerization of Epoxide and Lactone. Chinese Journal of Polymer Science. 2020 Apr 21;38(9):950–7. doi: 10.1007/s10118-020-2413-y.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知